Multiresistant acinetobacter in the UK: how big a threat?

J Hosp Infect. 2004 Nov;58(3):167-9. doi: 10.1016/j.jhin.2003.12.019.

Authors

J Coelho¹, N Woodford, J Turton, D M Livermore

Affiliation

¹ Antibiotic Resistance Monitoring and Reference Laboratory, Specialist and Reference Microbiology Division, Health Protection Agency-Colindale, 61 Colindale Avenue, London NW9 5HT, UK. [email protected]

PMID: 15501329
DOI: 10.1016/j.jhin.2003.12.019

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Acinetobacter / drug effects
Acinetobacter Infections / drug therapy
Acinetobacter Infections / epidemiology
Acinetobacter Infections / prevention & control*
Anti-Infective Agents / pharmacology
Anti-Infective Agents / therapeutic use
Cross Infection / drug therapy
Cross Infection / epidemiology
Cross Infection / prevention & control*
Drug Resistance, Multiple*
Humans
Infection Control
United Kingdom / epidemiology

Substances

Anti-Infective Agents